Evidence map›Paper›PMID 23089761›Full record

ArticleAntimicrobial agents and chemotherapy2013

Stepwise development of a homozygous S80P substitution in Fks1p, conferring echinocandin resistance in Candida tropicalis.

Rasmus Hare Jensen, Helle Krogh Johansen, Maiken Cavling Arendrup

Abstract readCase Reports
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Article
  2. The emerging threat antifungal-resistantFrontiers in fungal biology · 2022
    Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. An Update onFrontiers in microbiology · 2017
    Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Mechanisms of echinocandin antifungal drug resistance.Annals of the New York Academy of Sciences · 2015
    Review
  19. Article
  20. Echinocandin resistance: an emerging clinical problem?Current opinion in infectious diseases · 2014
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Rasmus Hare JensenMycology Unit, Statens Serum Institut, Copenhagen, Denmark.ORCID 0000-0002-9796-023X
Helle Krogh Johansen
Maiken Cavling Arendrup

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Three Candida tropicalis isolates were obtained from a patient with acute lymphoblastic leukemia. The first isolate was susceptible to all drug classes, while isolates 2 and 3, obtained after 8 and 8.5 weeks of caspofungin treatment, respectively, were resistant to the three echinocandins. Multilocus sequence genotyping suggested a clonal relation among all isolates. FKS1 sequencing revealed a stepwise development of a heterozygous and finally a homozygous mutation, leading to S80S/P and S80P amino acid substitutions.

Indexed as

HomozygoteAmino Acid SubstitutionAntifungal AgentsCandida tropicalisCandidiasisClone CellsDrug Resistance, FungalEchinocandinsFungal ProteinsGlucosyltransferasesHumansMicrobial Sensitivity TestsMultilocus Sequence TypingMutationPrecursor Cell Lymphoblastic Leukemia-LymphomaProlineAntifungal AgentsEchinocandinsFungal ProteinsGlucosyltransferasesProlineSerine

Identifiers

PMID23089761
PMCPMC3535961

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.